Duke of Gloucester opens Vindon headquarters in Rochdale, UK
Facilities to support growth plans
Vindon Scientific operates in several markets, including the healthcare, pharmaceutical, life sciences, food sectors and heritage sectors. It is a leading supplier of environmental control products and services for the management of temperature, humidity and light, where controlled environment storage is needed.
The Duke of Gloucester formally opened the new state-of-the-art premises and met Vindon’s directors who gave him a tour of the 29,000ft2 facilities, which are now fully operational and geared up to support the company's ambitious growth plans.
His Royal Highness was shown the specialist products and services that Vindon provides, including stability storage, ultra-low temperature facilities and cryogenic sample storage for stem cells.
‘It was good to see that companies such as Vindon were investing in future technologies,’ he said.
Patrick Jackson, business development director at Vindon, added: ‘We were delighted to welcome the Duke of Gloucester to our new home here at Kingsway. To be chosen to represent this area of Rochdale is a great honour. We’re pleased to see continued investment in the Business Park, which will encourage more new ventures to join us.’
The Lord Lieutenant of Greater Manchester, the Mayor of Rochdale, Zulfiqar Ali, and leader of Rochdale Council, Irene Davidson, accompanied HRH Duke of Gloucester on his visit.
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing
Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target
BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target